Literature DB >> 756881

The effect of indomethacin on plasma renin activity and urinary aldosterone of patients with essential hypertension.

R Pedrinelli, F Arzilli, L Cavasinni, L Poli, P Sassano, A Salvetti.   

Abstract

The effect of indomethacin on plasma renin activity (PRA), urinary aldosterone, 17 OH ketogenic steroids and plasma cortisol was studied in twenty-three patients with essential hypertension and compared in eleven patients to oxprenolol effect by 2 x 2 factorial trial. Indomethacin decreased PRA and urinary aldosterone: its effect was maintained when the drug was given for three days and it was related to basal PRA and aldosterone values. Therefore in patients with low PRA (renin-sodium index) PRA and aldosterone were unchanged, while they decreased in the normal high PRA group. Aldosterone changes were related to those of PRA, while 17 OH ketogenic steroids and plasma cortisol were unchanged. Both indomethacin and oxprenolol decreased PRA, but no interaction or additive effect was found between the two drugs. The present data indicate that indomethacin can decrease both PRA and aldosterone to an extent which is related to basal values and that aldosterone changes are mainly explained by those of PRA. The PRA unresponsiveness to indomethacin found in low renin patients may suggest renal prostaglandin deficiency. Finally the lack of interaction or of additive effect between indomethacin and oxprenolol may be explained by postulating either that the two drugs act on a common pathway or that an additive effect on PRA cannot be detected renin being maximally suppressed by full renal beta-receptors blockade.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 756881     DOI: 10.1007/BF03350976

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

1.  Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man.

Authors:  J H LARAGH; M ANGERS; W G KELLY; S LIEBERMAN
Journal:  JAMA       Date:  1960-09-17       Impact factor: 56.272

2.  Adrenocortical steroidogenesis: the effects of prostaglandins.

Authors:  T Saruta; N M Kaplan
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

3.  Measurement of plasma renin activity by angiotensin I radioimmunoassay: (I) an assessment of some methodological aspects.

Authors:  R Malvano; G C Zucchelli; U Rosa; A Salvetti
Journal:  J Nucl Biol Med       Date:  1972 Jan-Mar

4.  Effects of anti-inflammatory drugs on prostaglandin biosynthesis.

Authors:  R Flower; R Gryglewski; K Herbaczyńska-Cedro; J R Vane
Journal:  Nat New Biol       Date:  1972-07-26

5.  Renal actions of prostaglandins: comparison with acetylcholine and volume expansion.

Authors:  M Martinez-Maldonado; N Tsaparas; G Eknoyan; W N Suki
Journal:  Am J Physiol       Date:  1972-05

6.  Drugs which inhibit prostaglandin biosynthesis.

Authors:  R J Flower
Journal:  Pharmacol Rev       Date:  1974-03       Impact factor: 25.468

7.  Stimulation of renin release from rabbit renal cortex by arachidonic acid and prostaglandin endoperoxides.

Authors:  P C Webber; C Larsson; E Anggard; M Hamberg; E J Corey; K C Nicolaou; B Samuelsson
Journal:  Circ Res       Date:  1976-12       Impact factor: 17.367

8.  The effect of prostaglandin A1 on renin and aldosterone in man.

Authors:  M S Golub; P F Speckart; P K Zia; R Horton
Journal:  Circ Res       Date:  1976-10       Impact factor: 17.367

9.  Renin reactivity in plasma of patients with normal renin and low renin essential hypertension.

Authors:  C S Brooks; R T Talwalker; T A Kotchen
Journal:  J Clin Endocrinol Metab       Date:  1977-02       Impact factor: 5.958

10.  Role of prostaglandins in the control of renin secretion in the dog.

Authors:  J Yun; G Kelly; F C Bartter; H Smith
Journal:  Circ Res       Date:  1977-05       Impact factor: 17.367

View more
  4 in total

Review 1.  The involvement of arachidonic acid metabolism in the control of renin release.

Authors:  C Patrono; F Pugliese
Journal:  J Endocrinol Invest       Date:  1980 Apr-Jun       Impact factor: 4.256

2.  Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients.

Authors:  A Salvetti; F Arzilli; R Pedrinelli; P Beggi; M Motolese
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 3.  Do nonsteroidal anti-inflammatory drugs interfere with blood pressure control in hypertensive patients?

Authors:  K Radack; C Deck
Journal:  J Gen Intern Med       Date:  1987 Mar-Apr       Impact factor: 5.128

4.  Treatment of central serous chorioretinopathy with topical NSAIDs.

Authors:  Sepehr Bahadorani; Kyle Maclean; Kendall Wannamaker; Edward Rickie Chu; Nathan Gresores; Jeong-Hyeon Sohn; Roberto Diaz-Rohena; Michael A Singer
Journal:  Clin Ophthalmol       Date:  2019-08-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.